VYNE

Conviction 80HealthcareScan · Tue, Sep 8, 2026

VYNE$28.56+5511.00%

ResistanceSupportVol 14

Vol MA14 2.73M

Apr 27May 13Jun 2Jun 18Jul 9Jul 27

VYNE Therapeutics Inc. Common StockPHARMACEUTICAL PREPARATIONSwww.vynetherapeutics.com ↗

Price28.56

Change+5511.00%

Gap+4909.82%

Rel volume0.05×

Avg volume1.98M

Avg $ vol1.54M

SMA 202.11

SMA 501.24

SMA 2000.7029

Price vs 50+2200.90%

Price vs 200+3962.97%

MA stackbullish

50/200 cross—

Supertrendup · 17.28

RSI (14)99

MACD hist1.77

MACD crossbull · 0d

Stoch %K / %D100 / 68

ADX (14)37

+DI / −DI97 / 1

RSI divergence—

MACD divergenceBullish

ATR %+7.28%

ADR %7.69%

52w high28.56

52w low0.2870

From 52w high+0.00%

Above 52w low+9851.22%

New 52w highYes

SqueezeOff

Bollinger width1150.45%

%B1.59

Donchian pos100.00%

Donchian high28.56

Donchian low0.4700

AVWAP (52w high)26.83

vs AVWAP high+6.45%

AVWAP (52w low)0.5664

vs AVWAP low+4942.41%

OBV trendFlat

Chaikin MF (20)0.28

Today vs 20d0.05×

Avg vol (14d)2.73M

Avg vol (20d)1.98M

Avg $ vol (20d)1.54M

Market cap21.63M

RS 3m (vs SPY)+4323.70%

RS 6m (vs SPY)+4812.66%

RS line new highYes

Trend template8/8

Technical rank99.9

1 week+3435.53%

1 month+4282.38%

3 months+4327.22%

6 months+4819.90%

1 year+2031.34%

YTD+4824.99%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value—

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeXNAS

Shares out33.35M

Employees10

ListedThu, Jan 25, 2018

Free float31.6M

Float %94.8%

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank99.9 / 100

Group rank96 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.6924

Support0.6111

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in VYNE

All disclosures →

No recent disclosed trades by Congress in VYNE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VYNE · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Domzalski David PRESIDENT AND CEO · Common Stock · 2026-05-29	Grant	30.79K	$10K	2026-05-29	2026-06-02

SEC filings

EDGAR filings in VYNE · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.